Effectiveness of the pharmacological therapy to prevent post ERCP acute pancreatitis: a network meta-analysis

References

• Chen J-J, Wang X-M, Liu X-Q, et al. Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years. Eur J Med Res [Internet]. 2014;19(1):26. doi: 10.1186/2047-783X-19-26
   PubMed Web of Science ®Google Scholar
• Katsinelos P, Lazaraki G, Gkagkalis S, et al. Predictive factors for post-ERCP pancreatitis. Surg Laparosc Endosc Percutan Tech [Internet]. 2014;24(6):1. doi: 10.1097/SLE.0000000000000012
   PubMed Web of Science ®Google Scholar
• Ding X, Zhang FC, Wang YJ. Risk factors for post-ERCP pancreatitis: a systematic review and meta-analysis. Surgeon [Internet]. 2015;13(4):218–229. doi: 10.1016/j.surge.2014.11.005
   PubMed Web of Science ®Google Scholar
• Talukdar R. Complications of ERCP. Best Pract Res Clin Gastroenterol [Internet]. 2016;30(5):793–805. doi: 10.1016/j.bpg.2016.10.007
   PubMed Web of Science ®Google Scholar
• Tryliskyy Y, Bryce G. Post-ERCP pancreatitis: pathophysiology, early identification and risk stratification. Adv Clin Exp Med [Internet]. 2018;27(1):149–154. doi: 10.17219/acem/66773
   PubMed Web of Science ®Google Scholar
• Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc [Internet]. 2015 Jan 1 [cited 2020 Sep 30];81(1):143–149.e9. doi: 10.1016/j.gie.2014.06.045
   PubMed Web of Science ®Google Scholar
• Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med [Internet]. 2012;366(15):1414–1422. doi: 10.1056/NEJMoa1111103
   PubMed Web of Science ®Google Scholar
• Cooper ST, Slivka A. Incidence, risk factors, and prevention of post-ERCP pancreatitis. Gastroenterol Clin North Am. 2007;36(2):259–276. doi: 10.1016/j.gtc.2007.03.006
   PubMed Web of Science ®Google Scholar
• Choi JH, Kim HJ, Lee BU, et al. Vigorous periprocedural hydration with lactated ringer’s solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients. Clin Gastroenterol Hepatol [Internet]. 2017;15(1):86–92.e1. doi: 10.1016/j.cgh.2016.06.007
   PubMed Web of Science ®Google Scholar
• Park CH, Paik WH, Park ET, et al. Aggressive intravenous hydration with lactated ringer’s solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial. Endoscopy. 2018;50(4):378–385. doi: 10.1055/s-0043-122386
   PubMed Web of Science ®Google Scholar
• Yu G, Li S, Wan R. Et alNafamostat mesilate for prevention of post-ERCP pancreatitis. Pancreas. 2015;44(4):561–569. doi: 10.1097/MPA.0000000000000310
   PubMed Web of Science ®Google Scholar
• Ishiwatari H, Urata T, Yasuda I, et al. No benefit of oral diclofenac on post-endoscopic retrograde cholangiopancreatography pancreatitis. Dig Dis Sci. 2016;61(11):3292–3301. doi: 10.1007/s10620-016-4251-x
   PubMed Web of Science ®Google Scholar
• Sun HL, Han B, Zhai HP, et al. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Surgeon [Internet]. 2014;12(3):141–147. doi: 10.1016/j.surge.2013.10.010
   PubMed Web of Science ®Google Scholar
• Patai A, Solymosi N, Á V P. Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation. J Clin Gastroenterol. 2015;49(5):429–437. doi: 10.1097/MCG.0000000000000168
   PubMed Web of Science ®Google Scholar
• Kato K, Shiba M, Kakiya Y, et al. Celecoxib oral administration for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized prospective trial. Pancreas. 2017;46(7):880–886. doi: 10.1097/MPA.0000000000000852
   PubMed Web of Science ®Google Scholar
• Khoshbaten M, Khorram H, Madad L, et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol. 2008;23(7 PT2). doi: 10.1111/j.1440-1746.2007.05096.x
   PubMed Web of Science ®Google Scholar
• Levenick JM, Gordon SR, Fadden LL, et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients. Gastroenterology [Internet]. 2016;150(4):911–917. doi: 10.1053/j.gastro.2015.12.040
   PubMed Web of Science ®Google Scholar
• Lua GW, Muthukaruppan R, Menon J. Can rectal diclofenac prevent post endoscopic retrograde cholangiopancreatography pancreatitis? Dig Dis Sci. 2015;60(10):3118–3123. doi: 10.1007/s10620-015-3609-9
   PubMed Web of Science ®Google Scholar
• Mansour-Ghanaei F, Joukar F, Taherzadeh Z, et al. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: randomized controlled trial. World J Gastroenterol. 2016;22(21):5114–5121. doi: 10.3748/wjg.v22.i21.5114
   PubMed Web of Science ®Google Scholar
• Montaño Loza A, Rodríguez Lomelí X, García Correa JE, et al. Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes. Rev Esp Enferm Dig [Internet]. 2007;99(6):330–336. doi: 10.4321/s1130-01082007000600005
   PubMed Web of Science ®Google Scholar
• Murray B, Carter R, Imrie C, et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 2003;124(7):1786–1791. doi: 10.1016/s0016-5085(03)00384-6
   PubMed Web of Science ®Google Scholar
• Otsuka T, Kawazoe S, Nakashita S, et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol. 2012;47(8):912–917. doi: 10.1007/s00535-012-0554-7
   PubMed Web of Science ®Google Scholar
• Senol A, Saritas U, Demirkan H. Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis. World J Gastroenterol. 2009;15(32):3999–4004. doi: 10.3748/wjg.15.3999
   PubMed Web of Science ®Google Scholar
• Sotoudehmanesh R, Khatibian M, Kolahdoozan S, et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol. 2007;102(5):978–983. doi: 10.1111/j.1572-0241.2007.01165.x
   PubMed Web of Science ®Google Scholar
• Abu-Safieh Y, Altiti R, Lobadeh M. Diclofenac vs. Placebo in a randomized double blind controlled trial, in post ERCP pancreatitis. Am J Clin Med Res. 2014 Feb 28;2(2):43–46. doi: 10.12691/ajcmr-2-2-1
   Google Scholar
• Wen ZX, Jun BJ, Hu C, et al. Effect of diclofenac on the levels of lipoxin A4 and resolvin D1 and E1 in the post-ERCP pancreatitis. Dig Dis Sci. 2014;59(12):2992–2996. doi: 10.1007/s10620-014-3280-6
   PubMed Web of Science ®Google Scholar
• Park S, Chung M, Oh T, et al. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial. Endoscopy [Internet]. 2014 Nov 19 [cited 2020 Jun 3];47(1):33–39. doi: 10.1055/s-0034-1390743
   PubMed Web of Science ®Google Scholar
• Montaño-Loza A, García-Correa J, González-Ojeda A, et al. Prevención de hiperamilasemia y pancreatitis posterior a la colangiopancreatografía retrógrada endoscópica con la administración rectal de indometacina. Rev Gastroenterol Mex. 2006;71(3):262–268.
   PubMedGoogle Scholar
• Andrade-Dávila VF, Chávez-Tostado M, Dávalos-Cobián C, et al. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial. BMC Gastroenterol [Internet]. 2015;15(1):1–11. doi: 10.1186/s12876-015-0314-2
   PubMedGoogle Scholar
• Bhatia V, Ahuja V, Acharya SK, et al. A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. J Clin Gastroenterol. 2011;45(2):170–176. doi: 10.1097/MCG.0b013e3181eb600e
   PubMed Web of Science ®Google Scholar
• Cheon YK, Cho KB, Watkins JL, et al. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. Gastrointest Endosc. 2007 Dec;66(6):1126–1132.
   PubMed Web of Science ®Google Scholar
• Chik IAN, Jarmin R, Ariffin A, et al. A less invasive method of reducing the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: intravenous diclofenac sodium versus placebo. Asian J Pharm Clin Res. 2018 Oct 1;11(10):140–144. doi: 10.22159/ajpcr.2018.v11i10.26474
   Google Scholar
• de Quadros Onófrio F, Lima JCP, Watte G, et al. Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial. Surg Endosc Interv Technol. 2017;31(5):2317–2324. doi: 10.1007/s00464-016-5234-x
   PubMed Web of Science ®Google Scholar
• Döbrönte Z, Szepes Z, Izbéki F, et al. Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis? World J Gastroenterol. 2014;20(29):10151–10157. doi: 10.3748/wjg.v20.i29.10151
   PubMed Web of Science ®Google Scholar
• Fujita Y, Hasegawa S, Kato Y, et al. Intravenous injection of low-dose flurbiprofen axetil for preventing post-ERCP pancreatitis in high-risk patients: an interim analysis of the trial. Endosc Int Open. 2016;4(10):E1078–82. doi: 10.1055/s-0042-115172
   PubMedGoogle Scholar
• Katsinelos P, Kountouras J, Chatzis J, et al. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial. Gastrointest Endosc. 2005;61(3):407–415. doi: 10.1016/S0016-5107(04)02647-1
   PubMed Web of Science ®Google Scholar
• Martinez-Torres H, Rodriguez-Lomeli X, Davalos-Cobian C, et al. Oral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol. 2009;15(13):1600–1606. doi: 10.3748/wjg.15.1600
   PubMed Web of Science ®Google Scholar
• Mosler P, Sherman S, Marks J, et al. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointest Endosc. 2005;62(2):245–250. doi: 10.1016/S0016-5107(05)01572-5
   PubMed Web of Science ®Google Scholar
• Romagnuolo J, Hilsden R, Sandha GS, et al. Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial. Clin Gastroenterol Hepatol. 2008 Apr;6(4):465–471.
   PubMed Web of Science ®Google Scholar
• Katsinelos P, Fasoulas K, Paroutoglou G, et al. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Endoscopy. 2012;44(1):53–59. doi: 10.1055/s-0031-1291440
   PubMed Web of Science ®Google Scholar
• Lavy A, Karban A, Suissa A, et al. Natural β-carotene for the prevention of post-ERCP pancreatitis. Pancreas. 2004;29(2):e45–e50. doi: 10.1097/00006676-200408000-00018
   PubMed Web of Science ®Google Scholar
• Budzyńska A, Marek T, Nowak A, et al. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy. 2001;33(9):766–772. doi: 10.1055/s-2001-16520
   PubMed Web of Science ®Google Scholar
• Dumot JA, Conwell DL, Barry O’Connor J, et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol. 1998 Jan;93(1):61–65.
   PubMed Web of Science ®Google Scholar
• Sherman S, Blaut U, Watkins JL, et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc. 2003;58(1):23–29. doi: 10.1067/mge.2003.307
   PubMed Web of Science ®Google Scholar
• De Palma GD, Catanzano C. Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol. 1999 Apr;94(4):982–985. doi: 10.1111/j.1572-0241.1999.999_u.x
   PubMed Web of Science ®Google Scholar
• Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion. 1993;54(2):105–111. doi: 10.1159/000201021
   PubMed Web of Science ®Google Scholar
• Beauchant M, Ingrand P, Favriel JM, et al. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. Endoscopy. 2008 Aug;40(8):631–636.
   PubMed Web of Science ®Google Scholar
• Kaffes AJ, Bourke MJ, Ding S, et al. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc. 2006;64(3):351–357. doi: 10.1016/j.gie.2005.11.060
   PubMed Web of Science ®Google Scholar
• Kapetanos D, Kokozidis G, Christodoulou D, et al. A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis. Gastrointest Endosc. 2007;66(3):513–518. doi: 10.1016/j.gie.2007.03.1045
   PubMed Web of Science ®Google Scholar
• Moretó M, Zaballa M, Casado I, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc. 2003;57(1):1–7. doi: 10.1067/mge.2003.29
   PubMed Web of Science ®Google Scholar
• Hao JY, Wu DF, Wang YZ, et al. Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial. World J Gastroenterol. 2009;15(3):366–368. doi: 10.3748/wjg.15.366
   PubMed Web of Science ®Google Scholar
• Nøjgaard C, Hornum M, Elkjaer M, et al. Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial. Gastrointest Endosc. 2009;69(6):31–37. doi: 10.1016/j.gie.2008.11.042
   Google Scholar
• Barkay O, Niv E, Santo E, et al. Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial. Surg Endosc Interv Technol. 2008 Sep;22(9):1971–1976.
   PubMed Web of Science ®Google Scholar
• Rabenstein T, Fischer B, Wießner V, et al. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc. 2004;59(6):606–613. doi: 10.1016/S0016-5107(04)00159-2
   PubMed Web of Science ®Google Scholar
• Lee TY, Choi JS, Oh HC, et al. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study. Korean J Intern Med. 2015;30(5):602–609. doi: 10.3904/kjim.2015.30.5.602
   PubMed Web of Science ®Google Scholar
• Bai Y, Ren X, Zhang XF, et al. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial. Endoscopy. 2015 Jan 15;75:(5):12–25. doi: 10.1055/s-0034-1391227
   Google Scholar
• Bordas JM, Toledo V, Mondelo F, et al. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy. Horm Res [Internet]. 1988 [cited 2020 May 26];29(2–3):106–108. Available from: https://www.karger.com/Article/FullText/180981
   PubMedGoogle Scholar
• Ohuchida J, Chijiiwa K, Imamura N, et al. Randomized controlled trial for efficacy of nafamostat mesilate in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2015;44(3):415–421. doi: 10.1097/MPA.0000000000000278
   PubMed Web of Science ®Google Scholar
• Park KT, Kang DH, Choi CW, et al. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas. 2011;40(8):1215–1219. doi: 10.1097/MPA.0b013e31822116d5
   PubMed Web of Science ®Google Scholar
• Poon RTP, Yeung C, Lo CM, et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc. 1999;49(5):593–598. doi: 10.1016/S0016-5107(99)70387-1
   PubMed Web of Science ®Google Scholar
• Poon RTP, Yeung C, Liu CL, et al. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Gut. 2003 Dec;52(12):1768–1773.
   PubMed Web of Science ®Google Scholar
• Testoni PA, Bagnolo F, Andriulli A, et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther. 2001;15(7):965–972. doi: 10.1046/j.1365-2036.2001.01015.x
   PubMed Web of Science ®Google Scholar
• Thomopoulos KC, Pagoni NA, Vagenas KA, et al. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc. 2006;64(5):726–731. doi: 10.1016/j.gie.2006.03.934
   PubMed Web of Science ®Google Scholar
• Tsujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005;3(4):376–383. doi: 10.1016/S1542-3565(04)00671-8
   PubMed Web of Science ®Google Scholar
• Shah TU, Liddle R, Stanley Branch M, et al. Pilot study of aprepitant for prevention of post-ERCP pancreatitis in high risk patients: a phase ii randomized, double-blind placebo controlled trial. J Pancreas. 2012;13(5):514–518.
   PubMedGoogle Scholar
• Xiong GS, Wu SM, Zhang X-W, et al. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res. 2006;39(1):85–90. doi: 10.1590/S0100-879X2006000100010
   PubMed Web of Science ®Google Scholar
• Yoo K-S, Huh KR, Kim YJ, et al. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2011;40(2):181–186. doi: 10.1097/MPA.0b013e3181f94d46
   PubMed Web of Science ®Google Scholar
• Bordas JM, Toledo-Pimentel V, Llach J, et al. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc. 1998;47(3):230–234. doi: 10.1016/S0016-5107(98)70318-9
   PubMed Web of Science ®Google Scholar
• Yoo JW, Ryu JK, Lee SH, et al. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas. 2008;37(4):366–370. doi: 10.1097/MPA.0b013e31817f528f
   PubMed Web of Science ®Google Scholar
• Li ZS, Pan X, Zhang WJ, et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial - CME. Am J Gastroenterol. 2007 Jan;102(1):46–51.
   PubMed Web of Science ®Google Scholar
• Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med [Internet]. 1996 Sep 26 [cited 2020 May 26];335(13): 919–923. doi: 10.1056/NEJM199609263351302.
   PubMed Web of Science ®Google Scholar
• Chan HH, Lai KH, Lin CK, et al. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography. J Chin Med Assoc. 2008;71(12):605–609. doi: 10.1016/S1726-4901(09)70002-4
   PubMed Web of Science ®Google Scholar
• Choi CW, Kang DH, Kim GH, et al. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. Gastrointest Endosc. 2009 Apr;69(4). doi: 10.1016/j.gie.2008.10.046
   Web of Science ®Google Scholar
• Concepción-Martín M, Gómez-Oliva C, Juanes A, et al. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial. Endoscopy. 2014 Oct 1;46(10):851–856. doi: 10.1055/s-0034-1377306
   PubMed Web of Science ®Google Scholar
• Jowell PS, Branch MS, Fein SH, et al. Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatography. Pancreas. 2011;40(4):533–539. doi: 10.1097/MPA.0b013e3182152eb6
   PubMed Web of Science ®Google Scholar
• Lee KT, Lee DH, Yoo BM. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Pancreas. 2008 Nov;37(4):445–448. doi: 10.1097/MPA.0b013e3181733721
   PubMed Web of Science ®Google Scholar
• Manolakopoulos S, Avgerinos A, Vlachogiannakos, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc. 2002;55(4):470–475. doi: 10.1067/mge.2002.122614
   PubMed Web of Science ®Google Scholar
• Uchino R, Isayama H, Tsujino TY, et al. RESULTS of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial. Gastrointest Endosc [Internet]. 2013;78(6):842–850. doi: 10.1016/j.gie.2013.06.028
   PubMed Web of Science ®Google Scholar
• Hauser G, Blažević I, Salkić N, et al. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial. Surg Endosc. 2017;31(2):602–610. doi: 10.1007/s00464-016-5004-9
   PubMed Web of Science ®Google Scholar
• Masjedizadeh A, Fathizadeh P, Aghamohamadi N. Comparative effectiveness of aggressive intravenous fluid resuscitation with lactated Ringer’s solution and rectal indomethacin therapy in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a double blind randomised contr. Prz Gastroenterol. 2017;12(4):271–276. doi: 10.5114/pg.2017.72102
   PubMedGoogle Scholar
• Sotoudehmanesh R, Eloubeidi MA, Asgari AA, et al. A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis. Am J Gastroenterol [Internet]. 2014;109(6):903–909. doi: 10.1038/ajg.2014.9
   PubMed Web of Science ®Google Scholar
• Buxbaum J, Yan A, Yeh K, et al. Aggressive hydration with lactated ringer’s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol [Internet]. 2014;12(2):303–307.e1. doi: 10.1016/j.cgh.2013.07.026
   PubMed Web of Science ®Google Scholar
• Shaygan-Nejad A, Masjedizadeh AR, Ghavide A, et al. Aggressive hydration with lactated ringer’s solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled double-blind clinical trial. J Res Med Sci. 2015;20(9):838–843. doi: 10.4103/1735-1995.170597
   PubMed Web of Science ®Google Scholar
• Tsujino T, Isayama H, Nakai Y, et al. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial. J Gastroenterol. 2013;48(8):982–988. doi: 10.1007/s00535-012-0698-5
   PubMed Web of Science ®Google Scholar
• Akshintala VS, Hutfless SM, Colantuoni E, et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther [Internet]. 2013 Dec [cited 2020 Jun 30];38(11–12):1325–1337. doi: 10.1111/apt.12534
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Konjeti R, Lourdusamy V, et al. Precut sphincterotomy: efficacy for ductal access and the risk of adverse events. Gastrointest Endosc [Internet]. 2015 Apr 1 [cited 2020 Jun 30];81(4): 924–931. doi: 10.1016/j.gie.2014.09.015
   PubMed Web of Science ®Google Scholar
• Kubiliun NM, Adams MA, Akshintala VS, et al. Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review. Clin Gastroenterol Hepatol [Internet]. 2015 Jul 1 [cited 2020 Jul 2];13(7): 1231–1239. doi: 10.1016/j.cgh.2014.11.038
   PubMed Web of Science ®Google Scholar
• Lyu Y, Wang B, Cheng Y, et al. Comparative efficacy of 9 major drugs for postendoscopic retrograde cholangiopancreatography pancreatitis: a network meta-analysis. Surg Laparosc Endosc Percutaneous Tech [Internet]. 2019 Dec 1 [cited 2020 Jul 6];29(6): 426–432. doi: 10.1097/SLE.0000000000000707.
   PubMed Web of Science ®Google Scholar
• Zitinic I, Plavsic I, Poropat G, et al. ERCP induced and non-ERCP-induced acute pancreatitis: two distinct clinical entities? Med Hypotheses [Internet]. 2018;113(October 2017):42–44. doi: 10.1016/j.mehy.2018.02.017
   PubMedGoogle Scholar
• Tryliskyy Y, Bryce GJ. Post-ERCP pancreatitis: pathophysiology, early identification and risk stratification. Adv Clin Exp Med [Internet]. 2018 [cited 2020 Jul 2];27(1):149–154. doi: 10.17219/acem/66773
   PubMed Web of Science ®Google Scholar
• Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline [Internet]. Endoscopy. 2020 [cited 2020 Jul 2];52(2):127–149. doi: 10.1055/a-1075-4080
   PubMed Web of Science ®Google Scholar
• Mohammad Alizadeh AH, Abbasinazari M, Hatami B, et al. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. Eur J Gastroenterol Hepatol. 2017;29(3):349–54.
   PubMed Web of Science ®Google Scholar
• Devière J, Le Moine O, Van Laethem JL, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology. 2001 Feb 1;120(2):498–505.
   PubMed Web of Science ®Google Scholar
• Fujishiro H, Adachi K, Imaoka T, et al. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J Gastroenterol Hepatol. 2006;21(6):1065–9.
   PubMed Web of Science ®Google Scholar
• Hosseini M, Shalchiantabrizi P, Yektaroudy K, et al. Prophylactic effect of rectal indomethacin administration, with and without intravenous hydration, on development of endoscopic retrograde cholangiopancreatography pancreatitis episodes: A randomized clinical trial. Arch Iran Med. 2016;19(8):538–43.
   PubMed Web of Science ®Google Scholar
• Luo H, Zhao L, Leung J, et al. Routine preprocedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. Lancet [Internet]. 2016;387(10035): 2293. Available from: http://dx.doi.org/10.1016/S0140-6736(16)30310-5
   Google Scholar
• Manes G, Ardizzone S, Lombardi G, et al. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Gastrointest Endosc. 2007;65(7):982–7.
   PubMed Web of Science ®Google Scholar
• Masci E, Cavallini G, Mariani A, et al.Comparison of Two Dosing Regimens of Gabexate in the Prophylaxis of Post-ERCP Pancreatitis. Am J Gastroenterol. 2003;98(10):2182–6.
   PubMed Web of Science ®Google Scholar
• Park CH, Paik WH, Park ET, et al. Aggressive intravenous hydration with lactated Ringer’s solution for prevention of postERCP pancreatitis: A prospective randomized multicenter clinical trial. Endoscopy. 2018;50(4):378–85.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kang DH, Kim HW, et al. A Randomized Comparative Study of 24- and 6-Hour Infusion of Nafamostat Mesilate for the Prevention of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas. 2016;45:1179–1183.
   PubMed Web of Science ®Google Scholar